BFC Planning’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
BFC Planning's VRTX Position: Q3 2026 in Review
BFC Planning increased its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q3 2026, buying an estimated $48.6K and bringing the position to 2,051 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #374.
BFC Planning first reported a position in VRTX in Q3 2024 and has held it in 9 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- BFC Planning held 2,051 shares of Vertex Pharmaceuticals worth $1.07M as of Q3 2026.
- BFC Planning bought 95 Vertex Pharmaceuticals shares in Q3 2026, an estimated $48.6K.
- Vertex Pharmaceuticals made up 0.04% of BFC Planning's portfolio in Q3 2026, its #374 holding.
- BFC Planning first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.